期刊文献+

妇科恶性肿瘤患者术后病原菌分布及药敏分析 被引量:3

Distribution of pathogens in malignant tumor patients in gynecology department and drug susceptibility analysis
原文传递
导出
摘要 目的分析妇科恶性肿瘤患者术后感染的病原菌分布及耐药特点,为临床治疗及预防提供依据。方法选取医院2009年7月-2011年6月收治的妇科恶性肿瘤术后患者,对其送检标本病原菌种类及药敏试验结果进行分析,观察其病原菌分布及耐药特点。结果 201例感染患者共检出病原菌182株,其中革兰阳性菌93株,占51.1%,革兰阴性菌75株,占41.2%,真菌14株,占7.7%;产超广谱β-内酰胺酶大肠埃希菌检出20株,检出率为38.5%。结论妇科肿瘤患者感染病原菌耐药率较高,临床治疗中应根据其抗菌谱合理应用广谱抗菌药物,提高治疗效果。 OBJECTIVE To analyze the distribution and drug resistance of the pathogens causing infections in malignant tumor patients in gynecology department and provide basis for clinical prevention and treatment.METHODS The malignant tumor patients who enrolled in the gynecology department from Jul 2009 to Jun 2011 were selected,the species of the pathogens from the submitted specimens and the result of the drug susceptibility testing were analyzed,the characteristics of the distribution of the pathogens and the drug resistance were observed.RESULTS Of 201 patients,there were 182 strains of pathogens isolated,including 93 strains(51.1%) of gram-positive bacteria,75 strains(41.2%) of gram-negative bacteria,and 14 strains(7.7%) of fungi;there were 20 strains of ESBLs-producing Escherichia coli with the detection rate of 38.5%.CONCLUSION The drug resistance rate of the pathogens causing infections in gynecological tumor patients is so high that it is necessary to reasonably use broad spectrum antibiotics in line with the antibacterial spectrum so as to improve the therapeutic effect.
作者 邵峰
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第19期4396-4397,共2页 Chinese Journal of Nosocomiology
关键词 妇科 肿瘤 病原菌 药敏试验 感染 Gynecology department Tumor Pathogens Drug susceptibility Infection
  • 相关文献

参考文献5

二级参考文献12

  • 1郑百成,张秀春,陈建飞,杨军礼,胡华莉.恶性肿瘤患者发生医院感染分析[J].中华医院感染学杂志,2007,17(6):660-662. 被引量:15
  • 2Cisneros JM,Cobo J,Pujol M,etal. Guidelines for the diagnosis and treatment of patients with bacteriemia[S]. Enferm Infeect Microbiol Clin,2007,25(2) :111-130.
  • 3中华人民共和国卫生部.医院感染诊断标准[S].北京:中华人民共和国卫生部,2001:7-8.
  • 4Francesca R, Alessandra T, Enrica M,et al. Fludarabine in the treatment of chronic lymphocytic leukemia:a review[J]. Ther Clin Risk Manag, 2009,5 (1): 187- 207.
  • 5Bosch F, Ferrer A,Villarnor N, et al. Fludarabine, cyclophosphamide, and mitoxan-trone as initial therapy of chronic lymphocytic leukemia : high response rate and disease eradication[J]. Clin Cancer Res,2008,14(1) : 155-161.
  • 6Peralta G, Roiz MP, Sdnchez MB, et al. Timefto-positivity in patients with Escherichia coli bacteraemia[J]. Clin Micro- biol Infect,2007,13(11) :1077- 1082.
  • 7Marra AR, Edmond MB, Forbes BA, et al. Time to blood culture positivity as a predictor of clinical outcome of Staphy- lococcus aureus bloodstream infection[J]. J Clin Mierobiol, 2006,44(4) :1342 -1346.
  • 8Horvath LL, George Bj', Hospenthal DR. Detection of fif- teen species of eandida in an automated blood culture system [J]. J Clin Mierobiol,2007,45(9):3062-3064.
  • 9Ben-Ami R, Weinberger M, Orni-Wasserlauff R, et al. Time to blood culture positivity as a marker for catheter-related candidemia[J]. J Clin Microbiol, 2008,46 (7) : 2222-2226.
  • 10Khatib R, Riederer K, Saeed S, etal. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection[J]. Clin Infect Dis,2005, 41(5): 594-598.

共引文献34

同被引文献17

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部